• info@proteinlounge.com

Animations

Animations

Anti-PD-1 PD-L1 therapy of human cancer

Description

PD-L1,a 40kDa type 1 transmembrane protein, is a PD-1 ligand that can deliver inhibitory signals to PD-1+ T-cells to suppress immune responses. PD-L1 is widely expressed in cancer, where it contributes to immune evasion and facilitates tumor growth.

Immunotherapy for the treatment of cancer is rapidly evolving from therapies that globally and non-specifically simulate the immune system to more targeted activation of individual components of the immune system. More specifically, therapies that inhibit the interaction between PD-L1, present on the surface of tumor or antigen-presenting cells, and PD-1, present on the surface of activated lymphocytes, are generating much excitement and enthusiasm, even in malignancies that are not traditionally considered to be immunogenic.

Browse Other Animations

Kidney Stone Formation
Kidney stones (also called renal calculi) are hard deposits made of crystal-forming substances-[...]
Pathogenesis of SARS-CoV-2
The COVID-19 pandemic, also known as the coronavirus pandemic, is an ongoing global pandemic of[...]
Malaria
Malaria is a vector-borne infectious disease caused by a protozoan parasite of the genus[...]
Mechanism of Botulinum Toxin
Botulinum is a bacterial toxin produced by a bacteria Clostridium botulinum that causes the most[...]
logo

 

9853 Pacific Heights Blvd.
Suite D., San Diego, CA 92121, USA

Tel: 858-224-2869
Fax: 858-205-1192
info@proteinlounge.com

Institutional License

Need our databases and tools to be availed by your whole university or institute? We recommend signing up for our Site License.

To set up a license, please contact: info@proteinlounge.com

Copyright © Protein Lounge Inc.
   Terms & Conditions